Wheat bran and resistant starch may be cheap and effective new therapies for UC patients in remission, a small but promising Australian study presented at ECCO suggests.
The gastroenterologists from Box Hill Hospital in Victoria found patients with remitted UC have impaired utilisation of fibre in the gut and slow whole gut transit time.
But the single-blinded, randomised, cross-over trial found supplementation with high doses of wheat bran and resistant starch normalised the transit time and enhanced fibre utilisation.
The investigators – Dr Sally James and Professor Peter Gibson – found the 14 UC patients in remission who participated experienced no changes in clinical measures of their symptoms, disease activity of faecal lactoferrin on either the low dose (5g/day wheat bran, 2g/day resistant...
This site is intended for Registered Medical Practitioners.
To make the most of Gastroenterology Update, you need to be logged in.